Company / Depreciation & Amortization
RHYTHM PHARMACEUTICALS, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$500.0K
FY2025
5-year range
$500.0K / $900.0K
FY2021-FY2025
Trend
-28.6%
vs FY2024
Sector context
#135 of 168
Health Care
What the data says
RHYTHM PHARMACEUTICALS, INC.'s depreciation & amortization of $500,000 is lower than 80% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $144,000 in FY2016 to $900,000 in FY2023.
Based on SEC 10-K filings.
$500,000 in FY2025 with a 5-year CAGR of -6.2%.
Improved from $900,000 to $500,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- -6.2%
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.2%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 28.6% year-over-year.
- Ranks #135 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $500.0K | -28.6% |
| FY2024 | $700.0K | -22.2% |
| FY2023 | $900.0K | +0.4% |
| FY2022 | $896.0K | +9.8% |
| FY2021 | $816.0K | +18.3% |
| FY2020 | $690.0K | -17.3% |
| FY2019 | $834.0K | +88.7% |
| FY2018 | $442.0K | +98.2% |
| FY2017 | $223.0K | +54.9% |
| FY2016 | $144.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026